يعرض 31 - 40 نتائج من 130 نتيجة بحث عن '"G. Jerusalem"', وقت الاستعلام: 0.80s تنقيح النتائج
  1. 31
    Continuous vs intermittent adenosine 2A receptor (A2AR) inhibition in preclinical colon cancer (CC) models and in a Phase (Ph) II study of taminadenant (NIR178) + spartalizumab (PDR001) in patients (pts) with non-small cell lung cancer (NSCLC)

    المؤلفون: D.S.W. Tan, P. Grell, Felipe K. Hurtado, A.A. Chiappori, E. Morris, Niladri Roy Chowdhury, M.J.A. de Jonge, F. de Braud, Juergen Wolf, Stefan Kasper, J. Otero, G. Jerusalem, S. Chhagan, Anthony Gonçalves, D. Cipolletta, C-C. Lin, Ticiana A. Leal, Markus Joerger

    المصدر: European Journal of Cancer. 138:S12-S13

    مصطلحات موضوعية: Cancer Research, Colorectal cancer, business.industry, Medizin, non-small cell lung cancer (NSCLC), medicine.disease, Adenosine, Oncology, Cancer research, medicine, In patient, ComputingMethodologies_GENERAL, Receptor, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1127ff2047501097a48492fad784705Test
    https://doi.org/10.1016/s0959-8049Test(20)31098-4


    أضف إلى المفضلة
  2. 32
    329P Ribociclib (RIB) in patients (pts) with HR+/HER2− advanced breast cancer (ABC) and resistance to prior endocrine therapy (ET) in the MONALEESA (ML) -3 and -7 trials

    المؤلفون: Gabe S. Sonke, Agnes Lteif, Sara A. Hurvitz, G. Jerusalem, Y-S Lu, S-A. Im, S. Campos, H. Hu, Stephen Chia, Yirong Wang, Karen Rodriguez-Lorenc, S.C. Lee

    المصدر: Annals of Oncology. 31:S376-S377

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Advanced breast, Endocrine therapy, Cancer, Ribociclib, Hematology, medicine.disease, Internal medicine, medicine, In patient, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a32a3d9b2eb6789918feaa31bb47e1beTest
    https://doi.org/10.1016/j.annonc.2020.08.431Test


    أضف إلى المفضلة
  3. 33
    352TiP EPIK-B2: A phase III study of alpelisib (ALP) as maintenance therapy with trastuzumab (T) and pertuzumab (P) in patients (pts) with PIK3CA-mutated (mut) human epidermal growth factor receptor-2–positive (HER2+) advanced breast cancer (ABC)

    المؤلفون: Stephen Chia, Sara A. Hurvitz, Eva Ciruelos, G. Jerusalem, X. C. Hu, Mario E. Lacouture, S-A. Im, Hope S. Rugo, Farhat Ghaznawi, Yoon Sim Yap, Faye Su, Ruth O'Regan, Y. Han, Wolfgang Janni, Sarat Chandarlapaty

    المصدر: Annals of Oncology. 31:S389-S390

    مصطلحات موضوعية: business.industry, Advanced breast, Cancer, Hematology, medicine.disease, Oncology, Maintenance therapy, Trastuzumab, medicine, Cancer research, In patient, Pertuzumab, business, Human Epidermal Growth Factor Receptor 2, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::fd931f403469964c27d26d471fa5e283Test
    https://doi.org/10.1016/j.annonc.2020.08.454Test


    أضف إلى المفضلة
  4. 34
    276O Pooled analysis of patient (pt)-reported quality of life (QOL) in the MONALEESA (ML)-2, -3, and -7 trials of ribociclib (RIB) plus endocrine therapy (ET) to treat hormone receptor–positive, HER2-negative (HR+/HER2−) advanced breast cancer (ABC)

    المؤلفون: N.S. El Saghir, Wolfgang Janni, Arnd Nusch, Nadia Harbeck, A. Gaur, Aditya Bardia, Emilio Alba, A. Thuerigen, G. Jerusalem, Brad Lanoue, S-A. Im, A. Chan, David Chandiwana, PA Fasching

    المصدر: Annals of Oncology. 31:S350-S351

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Advanced breast, HER2 negative, Endocrine therapy, Cancer, Ribociclib, Hematology, medicine.disease, Pooled analysis, Quality of life, Hormone receptor, Internal medicine, medicine, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8945c7f80c90f6205c87dc75e41e84f3Test
    https://doi.org/10.1016/j.annonc.2020.08.378Test


    أضف إلى المفضلة
  5. 35
    دورية أكاديمية
    Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

    المؤلفون: M. Colleoni, W. Luo, P. Karlsson, J. Chirgwin, S. Aebi, G. Jerusalem, P. Neven, E. Hitre, M. Graas, E. Simoncini, C. Kamby, A. Thompson, S. Loibl, J. Gavilá, K. Kuroi, C. Marth, B. Müller, S. O'Reilly, V. Di Lauro, A. Gombos, T. Ruhstaller, H. Burstein, K. Ribi, J. Bernhard, G. Viale, R. Maibach, M. Rabaglio-Poretti, R. D. Gelber, A. S. Coates, A. Di Leo, M. M. Regan, A. Goldhirsch, A. Vandebroek, M. Berliere, C. Mitine, P. Vuylsteke, M. Borms, R. D'Hondt, P. Glorieux, J. Mebis, D. Verhoeven, M. Coibion, F. Forget, L. Duck, W. Wyendaele, A. Barbeaux, J. Salmon, P. Berteloot, J. Vermeij, V. Richard, S. Cinieri, L. Gianni, M. Clerico, G. Pinotti, A. Bernardo, L. Biganzoli, A. Gennari, C. Graiff, D. Amadori, R. Passalacqua, J. Forbes, P. Francis, S. Foo, F. Boyle, A. Redfern, A. van der Westhuizen, C. Lewis, S. Sharma, P. Beale, I. Byard, S. Begbie, F. Sardelic, E. Abdi, D. Clark, A. Chindewere, S. Della-Fiorentina, R. Asghari, M. Islam, L. Na Teo, S. White, L. Gilbert, K. Gardner, C. Uhlmann, D. Rauch, M. Mannhart, K. Buser, K. Dedes, A. Mueller, C. Rageth, S. Von Orelli, H. J. Senn, O. Pagani, A. Pedrazzini, C. Rochlitz, A. Bodmer, S. Anchisi, K. Zaman, R. von Moos, D. Betticher, E. Kralidas, R. Popescu, M. Fehr, P. Nyman, A. Jungquist, C. Chamalidou, T. Foukakis, C. Dabrosin, A. Valachis, I. Lang, Z. Kahan, J. Retamales, U. R. Torres, M. Fritis, S. Sole, S. Torres, J. Letzkus, P. Escobar, I. Vigneaux, J. Arancibia, J. B. Cardemil, P. Huidobro, H. Gomez, J. Wetter, D. Vorobiof, G. Mcmichael, J. Apffelstaedt, I. Vorotnikov, J. Schwartz, T. Openshaw, H. Bonnefoi, J. Jacquin, N. Bonichon-Lamichhane, S. Borstner, A. Budrukkar, M. Ewertz, O. Z. Quispe, P. M. Vestlev, H. Danø, D. Nielsen, E. Jakobsen, I. Hoejris, J. A. Bogovic, B. B. Jensen, K. Aage Møller, E. L. Stenbygaard, R. Sharma, C. Bedi, M. Bews-Hair, G. Neades, M. Mckirdy, M. Barber, A. Alhasso, D. Ritchie, J. Fraser, L. Scott, F. Yuille, A. Lannigan, D. Murphy, M. Shere, C. Jackisch, O. Tomé, S. Steer, D. Augustin, K. Lübbe, H. Köcker-Korus, J. Deuker, A. Stefek, M. Just, U. Rhein, C. Bechtner, D. Baerens, I. Schrader, E. Grischke, R. Lorenz, W. Dietz, J. Thomalla, J. Schilling, A. Rempen, H. Graf, G. Doering, S. Busch, G. Heinrich, H. Tesch, C. Uleer, P. Krabisch, S. Rösel, C. Kurbacher, H. Ostertag, K. Josten, C. Hielscher, I. Gröll, U. M. Mattner, A. Prechtl, T. Lantzsch, E. Ciruelos, I. Garau, M. Bellet, M. A. Climent, R. López, J. A. Virizuela, B. Bermejo, N. M. Janez, K. Amillano, R. Márquez, J. Dorca, M. J. Godes, S. Gonzalez, S. Ohno, T. Aruga, D. Yotsumoto, Y. Yamamoto, T. Aihara, T. Morimoto, H. Bando, N. Masuda, M. Toi, K. Aogi, N. Sato, M. Okada, M. Takahashi, E. Tokunaga, H. Iwata, T. Fujita, M. Fridrik, G. Pristauz, C. Hackl, C. Singer, V. Wette, M. Gnant, J. Thaler, R. Greil, B. Abendstein, D. Heck, D. Manfreda, P. Sevelda, I. Thiel, F. Tuttlies, H. Stöger, W. Neunteufel, J. Crown, J. Kennedy, A. Hill, J. Mccaffrey, C. Murphy, L. Coate, M. Keane, M. Martin, M. O'Connor, K. Duffy, B. Ruepp, M. Piccart, D. Zardavas

    المساهمون: M. Colleoni, W. Luo, P. Karlsson, J. Chirgwin, S. Aebi, G. Jerusalem, P. Neven, E. Hitre, M. Graa, E. Simoncini, C. Kamby, A. Thompson, S. Loibl, J. Gavilá, K. Kuroi, C. Marth, B. Müller, S. O'Reilly, V. Di Lauro, A. Gombo, T. Ruhstaller, H. Burstein, K. Ribi, J. Bernhard, G. Viale, R. Maibach, M. Rabaglio-Poretti, R.D. Gelber, A.S. Coate, A. Di Leo, M.M. Regan, A. Goldhirsch, A. Vandebroek, M. Berliere, C. Mitine, P. Vuylsteke, M. Borm, R. D'Hondt, P. Glorieux, J. Mebi, D. Verhoeven, M. Coibion, F. Forget, L. Duck, W. Wyendaele, A. Barbeaux, J. Salmon, P. Berteloot, J. Vermeij, V. Richard, S. Cinieri, L. Gianni, M. Clerico, G. Pinotti, A. Bernardo, L. Biganzoli, A. Gennari, C. Graiff, D. Amadori, R. Passalacqua, J. Forbe, P. Franci, S. Foo, F. Boyle, A. Redfern, A. van der Westhuizen, C. Lewi, S. Sharma, P. Beale, I. Byard, S. Begbie, F. Sardelic, E. Abdi, D. Clark, A. Chindewere, S. Della-Fiorentina, R. Asghari, M. Islam, L. Na Teo, S. White, L. Gilbert, K. Gardner, C. Uhlmann, D. Rauch, M. Mannhart, K. Buser, K. Dede, A. Mueller, C. Rageth, S. Von Orelli, H.J. Senn, O. Pagani, A. Pedrazzini, C. Rochlitz, A. Bodmer, S. Anchisi, K. Zaman, R. von Moo, D. Betticher

    مصطلحات موضوعية: Oncology, Settore MED/08 - Anatomia Patologica

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29158011; info:eu-repo/semantics/altIdentifier/wos/WOS:000419018200060; volume:19; issue:1; firstpage:127; lastpage:138; numberofpages:12; journal:THE LANCET ONCOLOGY; http://hdl.handle.net/2434/548634Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85034830222

    الإتاحة: https://doi.org/10.1016/S1470-2045Test(17)30715-5
    http://hdl.handle.net/2434/548634Test

    View record in BASE

    أضف إلى المفضلة
  6. 36
    Abstract PS5-05: Serum thymidine kinase activity in patients with luminal metastatic breast cancer treated with palbociclib and fulvestrant within the PYTHIA trial

    المؤلفون: Manuela Rabaglio, Meredith M. Regan, Iain MacPherson, Patrick Neven, Marco Colleoni, Svitlana Tyekucheva, Luca Malorni, Heidi De Swert, Konstantinos Papadimitriou, Martine Piccart, Michail Ignatiadis, Francois Duhoux, Amelia McCartney, Florentine Hilbers, G. Jerusalem, Alberto Ballestrero, Alastair Thomson, M. Benelli, Antonio Bernardo, Stephanie Henry, David Mark Davies, Rudolf Maibach, Andrea Bonetti, Barbara Ruepp, Mattias Bergqvist

    المصدر: Cancer Research. 81:PS5-05

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Thymidine kinase activity, Fulvestrant, business.industry, Hazard ratio, Cancer, Palbociclib, medicine.disease, Metastatic breast cancer, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Breast cancer, 030220 oncology & carcinogenesis, Internal medicine, medicine, Thymidine kinase 1, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c109b5944d253718b7bf57e621f67040Test
    https://doi.org/10.1158/1538-7445.sabcs20-ps5-05Test


    أضف إلى المفضلة
  7. 37
    Abstract P5-15-05: Randomized phase II study evaluating different schedules of nab-paclitaxel in metastatic breast cancer (MBC): Results of the SNAP study

    المؤلفون: Zhuoxin Sun, K Amillano Parraga, Meredith M. Regan, R. von Moos, O. Pagani, Janice M. Walshe, Bryan T. Hennessy, G. Jerusalem, M.A. Colleoni, Alessandra Gennari, A Barbeaux, John James Kennedy, Maria Vidal, U Hasler-Strub, Simona Borštnar, Rudolf Maibach, J. Cortes, S Morales Murrillo, Manuela Rabaglio

    المصدر: Cancer Research. 77:P5-15

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, business.industry, Snap, Phases of clinical research, medicine.disease, Metastatic breast cancer, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, business, Nab-paclitaxel

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::da3a21a680c684ea8303d53313aa6a81Test
    https://doi.org/10.1158/1538-7445.sabcs16-p5-15-05Test


    أضف إلى المفضلة
  8. 38
    144P Patient-reported outcomes (PROs) in advanced breast cancer (ABC) treated with ribociclib (RIB) + fulvestrant (FUL) as first-line (1L) and second-line (2L) therapy in MONALEESA-3 (ML-3)

    المؤلفون: Peter A. Fasching, Brad Lanoue, Karen Rodriguez-Lorenc, Patrick Neven, G. Jerusalem, A. Gaur, Manu Sondhi, Arnd Nusch, M. Martin Jimenez, Giancarlo Bianchi, M. De Laurentiis, A. Chan, David Chandiwana, JT Beck, S Chia

    المصدر: Annals of Oncology. 31:S67-S68

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Fulvestrant, business.industry, Advanced breast, First line, Cancer, Ribociclib, Hematology, medicine.disease, Second line, Internal medicine, Medicine, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d5241dbbd8e559794022891dde731117Test
    https://doi.org/10.1016/j.annonc.2020.03.245Test


    أضف إلى المفضلة
  9. 39
    Overall survival (OS) results of the phase III MONALEESA-3 trial of postmenopausal patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2−) advanced breast cancer (ABC) treated with fulvestrant (FUL) ± ribociclib (RIB)

    المؤلفون: JT Beck, Xavier Pivot, Arnd Nusch, L. De la Cruz-Merino, Gabe S. Sonke, Patrick Neven, Manu Sondhi, Karen Rodriguez-Lorenc, K. Petrakova, Peter A. Fasching, S Chia, Francisco J. Esteva, DJ Slamon, M. Martin, G. Jerusalem, S.-A. Im, Giancarlo Bianchi, Yirong Wang, Arunava Chakravartty, M. De Laurentiis

    المصدر: Annals of Oncology. 30:v856-v857

    مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Time to progression, business.industry, Human epidermal growth factor, Advanced breast, Steering committee, Stock options, Ribociclib, Hematology, 03 medical and health sciences, Safety profile, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Family medicine, Overall survival, Medicine, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1d2c988298c0c6cd836dd895b391a5ecTest
    https://doi.org/10.1093/annonc/mdz394.007Test


    أضف إلى المفضلة
  10. 40
    دورية أكاديمية
    © 2003 European Society for Medical Oncology Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease

    المؤلفون: G. Jerusalem, Y. Beguin, M. F. Fassotte, T. Belhocine, R. Hustinx, P. Rigo, G. Fillet

    المساهمون: The Pennsylvania State University CiteSeerX Archives

    المصدر: http://annonc.oxfordjournals.org/content/14/1/123.full.pdfTest.

    وصف الملف: application/pdf

    العلاقة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.588.567Test; http://annonc.oxfordjournals.org/content/14/1/123.full.pdfTest

    الإتاحة: http://annonc.oxfordjournals.org/content/14/1/123.full.pdfTest

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث